162 related articles for article (PubMed ID: 29846633)
41. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
42. An orthotopic model of papillary thyroid carcinoma in athymic nude mice.
Ahn SH; Henderson Y; Kang Y; Chattopadhyay C; Holton P; Wang M; Briggs K; Clayman GL
Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):190-7. PubMed ID: 18283163
[TBL] [Abstract][Full Text] [Related]
43. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
[TBL] [Abstract][Full Text] [Related]
44. Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation.
Afkhami M; Karunamurthy A; Chiosea S; Nikiforova MN; Seethala R; Nikiforov YE; Coyne C
Thyroid; 2016 Feb; 26(2):242-7. PubMed ID: 26422023
[TBL] [Abstract][Full Text] [Related]
45. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
46. Establishment and characterization of a human papillary thyroid carcinoma cell line with oxyphilic differentiation (ONCO-DG 1).
Grimm D; Hofstädter F; Bauer J; Spruss T; Steinbach P; Bernhardt G; Menze R
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(2):97-104. PubMed ID: 1381131
[TBL] [Abstract][Full Text] [Related]
47. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
48. Molecular pathology of differentiated thyroid cancer.
Greco A; Borrello MG; Miranda C; Degl'Innocenti D; Pierotti MA
Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):440-53. PubMed ID: 19910897
[TBL] [Abstract][Full Text] [Related]
49. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract][Full Text] [Related]
50. Mutation profile of differentiated thyroid tumours in an Australian urban population.
Mond M; Alexiadis M; Fuller PJ; Gilfillan C
Intern Med J; 2014 Aug; 44(8):727-34. PubMed ID: 24862939
[TBL] [Abstract][Full Text] [Related]
51. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of
Ibrahimpasic T; Xu B; Landa I; Dogan S; Middha S; Seshan V; Deraje S; Carlson DL; Migliacci J; Knauf JA; Untch B; Berger MF; Morris L; Tuttle RM; Chan T; Fagin JA; Ghossein R; Ganly I
Clin Cancer Res; 2017 Oct; 23(19):5970-5980. PubMed ID: 28634282
[No Abstract] [Full Text] [Related]
52. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
Zhang Y; Li F; Chen J
Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
[TBL] [Abstract][Full Text] [Related]
53. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
[TBL] [Abstract][Full Text] [Related]
54. Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.
Hardin H; Yu XM; Harrison AD; Larrain C; Zhang R; Chen J; Chen H; Lloyd RV
Am J Pathol; 2016 Jun; 186(6):1662-73. PubMed ID: 27060227
[TBL] [Abstract][Full Text] [Related]
55. Multistep carcinogenesis in anaplastic thyroid carcinoma: a case report.
Asakawa H; Kobayashi T
Pathology; 2002 Feb; 34(1):94-7. PubMed ID: 11902457
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma.
Caria P; Dettori T; Frau DV; Di Oto E; Morandi L; Parmeggiani A; Tallini G; Vanni R
Am J Surg Pathol; 2012 Sep; 36(9):1415-20. PubMed ID: 22895275
[TBL] [Abstract][Full Text] [Related]
57. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
[TBL] [Abstract][Full Text] [Related]
58. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
59. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
Dettmer MS; Schmitt A; Steinert H; Capper D; Moch H; Komminoth P; Perren A
Endocr Relat Cancer; 2015 Jun; 22(3):419-29. PubMed ID: 25870252
[TBL] [Abstract][Full Text] [Related]
60. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors.
Namba H; Yamashita S; Pei HC; Ishikawa N; Villadolid MC; Tominaga T; Kimura H; Tsuruta M; Yokoyama N; Izumi M
Endocrinol Jpn; 1991 Dec; 38(6):627-32. PubMed ID: 1823030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]